January 2018

With its three judgements of 19 December 2017 the Federal Administrative Court reverses the sanctions against Pfizer, Eli Lilly and Bayer imposed by the Competition Commission which totaled in CHF 5.7 million. The court concludes that the non-binding price recommendations published by the three pharmaceutical companies did not restrict competition but rather prevented excessive prices.